Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis.
Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis.
复制标题
DOI:
10.1016/j.tube.2011.06.009
复制
发表时间:
2011-11
期刊:
影响因子:
--
通讯作者:
Scriba TJ
中科院分区:
文献类型:
--
作者:
Matthews K;Wilkinson KA;Kalsdorf B;Roberts T;Diacon A;Walzl G;Wolske J;Ntsekhe M;Syed F;Russell J;Mayosi BM;Dawson R;Dheda K;Wilkinson RJ;Hanekom WA;Scriba TJ
The inflammatory response to Mycobacterium tuberculosis (M.tb) at the site of disease is Th1 driven. Whether the Th17 cytokines, IL-17 and IL-22, contribute to this response in humans is unknown. We hypothesized that IL-17 and IL-22 contribute to the inflammatory response in pleural and pericardial disease sites of human tuberculosis (TB). We studied pleural and pericardial effusions, established TB disease sites, from HIV-uninfected TB patients. Levels of soluble cytokines were measured by ELISA and MMP-9 by luminex. Bronchoalveolar lavage or pericardial mycobacteria-specific T cell cytokine expression was analyzed by intracellular cytokine staining. IL-17 was not abundant in pleural or pericardial fluid. IL-17 expression by mycobacteria-specific disease site T cells was not detected in healthy, M.tb-infected persons, or patients with TB pericarditis. These data do not support a major role for IL-17 at established TB disease sites in humans. IL-22 was readily detected in fluid from both disease sites. These IL-22 levels exceeded matching peripheral blood levels. Further, IL-22 levels in pericardial fluid correlated positively with MMP-9, an enzyme known to degrade the pulmonary extracellular matrix. We propose that our findings support a role for IL-22 in TB-induced pathology or the resulting repair process.
登录
查看更多内容
影响因子:
4.4
作者:
Scriba, Thomas J.;Kalsdorf, Barbara;Abrahams, Deborah-Ann;Isaacs, Fatima;Hofmeister, Jessica;Black, Gillian;Hassan, Hisham Y.;Wilkinson, Robert J.;Walzl, Gerhard;Gelderbloem, Sebastian J.;Mahomed, Hassan;Hussey, Gregory D.;Hanekom, Willem A.
通讯作者:
Hanekom, Willem A.
DOI:
10.1084/jem.20082683
发表时间:
2009-07-06
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Pickert G;Neufert C;Leppkes M;Zheng Y;Wittkopf N;Warntjen M;Lehr HA;Hirth S;Weigmann B;Wirtz S;Ouyang W;Neurath MF;Becker C
通讯作者:
Becker C
影响因子:
5.8
作者:
Flynn, JoAnne L.
通讯作者:
Flynn, JoAnne L.
影响因子:
11.8
作者:
Wilkinson, KA;Wilkinson, RJ;Lalvani, A
通讯作者:
Lalvani, A
影响因子:
3.2
作者:
Hoheisel, G;Sack, U;Schauer, J
通讯作者:
Schauer, J